Picture of Bioventus logo

BVS Bioventus News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapSuper Stock

Bioventus Inc expected to post earnings of 12cents a share - Earnings Preview

* Bioventus Inc  BVS.OQ   BVS.O  is expected to show a rise
in
quarterly revenue when it reports  results on November 8. 
    * The Durham North Carolina-based  company is expected to
report 
a 30.0% increase in revenue to $141.592 million from $108.89
million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Bioventus Inc is
for
earnings of 12 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Bioventus
Inc is
$15.5​, above​ its last closing price of $7.17. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  0.15        0.16       0.10      Missed  -35.9
 Mar. 31 2022  0.05        0.05       0.04      Missed  -16.7
 Dec. 31 2021  0.17        0.18       0.26      Beat    46.5​
 Sep. 30 2021  0.14        0.14       0.25      Beat    78.6
 ​​Jun.        0.10        0.14       0.16      Beat    16.4
 30 2021                                                
 Mar. 31 2021  0.10        0.10       0.15      Beat    57.9​
 Dec. 31 2020  0.23        0.23       2.32      Beat    908.7
 This summary was machine generated November 4 at 19:31 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Bioventus

See all news